Home   novartis  

novartis

Ad

Novartis

Novartis International AG is a Swiss multinational multinationalpharmaceutical company based in multinationalpharmaceutical companyBasel , Switzerland, ranking number one in sales (57.9 billion US$) among the world-wide industry in 2013. In July 2015, Novartis had a market-cap of around $280 billion making it the largest healthcare company by this metric.Novartis manufactures such drugs as salesclozapine (Clozaril), salesclozapinediclofenac (Voltaren), salesclozapinediclofenaccarbamazepine... read more

Novartis Foundation

The Novartis Foundation (formerly known as the Novartis Foundation for Sustainable Development) is a non-profit organization and part of the corporate responsibility portfolio of Novartis. Its place of residence is in Basel, Switzerland. The foundation is a competence center for international health cooperation. The foundation initiates and conducts projects to improve health, mostly in sub-Saharan Africa and in south-east Asia.== History ==The Novartis Foundation has been one of the leading organizations... read more

Novartis Institute for Tropical Diseases

The Novartis Institute for Tropical Disease (NITD) is a Singapore-based tropical disease research institute created through a public-private partnership between Novartis and the Singapore Economic Development Board. Research at NITD focuses primarily on developing novel small molecule therapies for tropical infectious diseases that are endemic to the developing world, particularly dengue fever, malaria and tuberculosis.==History and mission==NITD was founded in 2002 as a public-private partnership... read more

Novartis Foundation for Sustainable Development

The Novartis Foundation (formerly known as the Novartis Foundation for Sustainable Development) is a non-profit organization and part of the corporate responsibility portfolio of Novartis. Its place of residence is in Basel (Switzerland). The Novartis Foundation is a competence center for international health cooperation. The foundation initiates and conducts projects to improve health, mostly in sub-Saharan Africa and in south-east Asia.== History ==The Novartis Foundation has been one of the leading... read more

Novartis v. Union of India & Others

''Novartis v. Union of India & Others'' is a landmark decision by a two-judge bench of the Indian Supreme Court on the issue of whether Novartis could patent Gleevec in India, and was the culmination of a seven-year-long litigation fought by Novartis. The Supreme Court upheld the Indian patent office's rejection of the patent application.The patent application at the center of the case was filed by Novartis in India in 1998, after India had agreed to enter the World Trade Organization and to abide... read more

Genomics Institute of the Novartis Research Foundation

The Genomics Institute of the Novartis Research Foundation (GNF) is a research institution specializing in basic biological as well as drug discovery research using high-throughput techniques. The institute was originally known as the Novartis Institute for Functional Genomics and this name is still used sometimes. It is a research center located in the Torrey Pines Science Park in La Jolla, California, and was started in 1999. The institute was originally funded through the Novartis Foundation... read more

Template:Did you know nominations/Novartis v. Union of India & Others

====Novartis v. Union of India & Others====... that Supreme Court of India in ''Novartis v. Union of India & Others'' rejected patent protection for stereoisomers of cancer drug Imatinib?Created by User:Legaleagle86 (talk). Self nom at 10:10, 5 April 2013 (UTC). read more

Tixylix

Tixylix is a range of cough and cold medicines from Novartis. read more

Fenistil

Fenistil is a brand name for some over the counter medications distributed by GlaxoSmithKline and Novartis. read more

Fadrozole

Fadrozole (INN, marketed as Afema by Novartis) is a selective aromatase inhibitor that has been introduced in Japan for the treatment of breast cancer. read more

Hygroton

Hygroton is a trademark of Novartis Pharmaceuticals for Chlorthalidone, an antihypertensive diuretic based on Thiazide. Other drugs in this category include Bendroflumethiazide, Chlorothiazide, Hydrochlorothiazide, Hydroflumethiazide, Methyclothiazide, Metolazone, Polythiazide, Quinethazone, and Trichlormethiazide. It is not marketed by Novartis Pharmaceuticals UK read more

Lasinavir

Lasinavir (INN, previously known as BMS-234475 and CGP-61755) is an experimental peptidomimetic protease inhibitor researched by Novartis and Bristol-Myers Squibb as a treatment for HIV infection. It was originally discovered by Novartis at Basel (Switzerland).Its investigation was terminated after Phase I on October 09, 2002. read more

Joseph Jimenez

Joseph Jimenez is the CEO of the Swiss pharmaceutical company Novartis.==Education==Jimenez earned a bachelor's degree from Stanford University in 1982, and an MBA from University of California, Berkeley in 1984.===Early career===Jimenez began his career at Clorox before joining ConAgra Foods. Prior to joining Novartis, he was head of H. J. Heinz Company's North American business from 2002 to 2006. He was also a non-executive director of AstraZeneca from 2002 to 2007, as well as an advisor for the... read more

MF59

MF59 is an immunologic adjuvant that uses squalene. It is Novartis' proprietary adjuvant that is added to influenza vaccines to help stimulate the human body's immune response through production of CD4 memory cells. MF59 is the first oil-in-water influenza vaccine adjuvant to be commercialized in combination with a seasonal influenza virus vaccine. MF59 is used as an adjuvant in Europe and in the United States. It was developed in the 1990s by researchers at Chiron Corporation, a Novartis heritage... read more

Thomas Strüngmann

Thomas Strüngmann (born 1950) founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. In February he and his brother Andreas sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion. read more

Ad

© 2016 Encyclopediasearch.com All rights reserved. Licensed under CC-BY-SA.